Novel therapy delays muscle atrophy in Lou Gehrig's disease model

July 12th, 2018 | Posted by admin in Uncategorized

Supplementing a single protein found in the spinal cord could help prevent symptoms of Lou Gehrig's disease, according to a new study. Researchers found high levels of the protein -- called mitofusion 2 or Mfn2 -- prevented nerve degeneration, muscle atrophy, and paralysis in a mouse model of the disease. Since Mfn2 is often depleted during Lou Gehrig's, the new study suggests supplementing it could be a novel therapeutic approach for the disease.
Source: Medicine Science Daily

You can follow any responses to this entry through the RSS 2.0 You can leave a response, or trackback.

Leave a Reply

Your email address will not be published. Required fields are marked *